Plasmodium

MICROBIOLOGY

  • Malaria is caused by Plasmodium protozoa belonging to the Apicomplexa group that are transmitted by nighttime or pre-dawn-biting female Anopheles sp. mosquitoes.
  • Life cycle: A female Anopheline mosquito bites a human host and injects sporozoites, which invade hepatocytes and mature into schizonts (exo-erythrocytic schizogony).
    • Schizonts rupture and release merozoites that invade RBCs. In RBCs, ring-stage trophozoites mature into blood schizonts (erythrocytic schizogony), followed by rupture of RBCs and a new cycle of RBC invasion.
      • Some trophozoites mature into gametocytes that are ingested by a mosquito during a blood meal.
      • The male and female gametocytes generate zygotes which develop into sporozoites as part of the sporogonic life cycle.
    • Naturally acquired immunity allows low-level parasitemia without acute illness to persist for prolonged periods.
    • The term ’invisible’ malaria recognizes the prevalence of asymptomatic malaria infections in endemic settings that go undetected by microscopy and rapid diagnostic immunochromatographic tests (RDTs).[13]
    • As the global strategy for malaria control hinges on diagnosis and treatment of those with symptomatic infection, malaria transmission persists, in part, as a result of ongoing infection of mosquitoes due to frequent, subclinical episodes of parasitemia in humans.[13]
  • In 2022, the CDC confirmed 1,999 cases of malaria in the U.S. Most cases originated in Africa (90%); of those cases, 65% were imported from West Africa.[31]
    • In 2023, among the total of 2,627 cases of imported malaria (the highest ever), 10 autochthonous mosquito-transmitted cases occurred in four states: 7 FL P. vivax, 1 TX P. vivax, 1 AR P. vivax, and 1 MD P. falciparum, showing the potential for acquiring infection without travel outside the US.[12]
    • P. falciparum causes 84.5% of cases in the U.S.
      • Since P. falciparum invades erythrocytes of all life stages, it causes the most severe and lethal disease.
      • Endothelial cytoadherence causes infected erythrocytes to sequester in the microvasculature and damage the heart, brain, kidney, lung, and placenta.[27]
    • P. vivax causes 8.9% of cases in the U.S.
      • P. vivax is the most common type of Plasmodium spp. diagnosed outside of sub-Saharan Africa and survives at lower temperatures and higher elevations.
      • It preferentially invades reticulocytes via Duffy binding proteins and reticulocyte binding proteins.[29] Duffy-negative people express Duffy factor on reticulocytes and erythroblasts, which are vulnerable to P. vivax invasion.[13]
      • Due to its persistence in hepatocytes for months to years as hypnozoites, eradicating P. vivax requires treatment to eliminate both the liver stage (hypnozoite) and blood stage (schizont).
    • P. ovale causes 3.6% of cases in the U.S.
      • Due to persistence of P. ovale in the hepatocyte for months to years, eradication requires treatment of both the liver and blood stages.
      • Subclinical, low-density parasitemias may frequently recur and go undetected.[17] For example, PCR-based screening for non-falciparum malaria has found a higher prevalence of P. ovale compared to P. falciparum in Tanzania.[15]
    • P. malariae causes a small number of cases in the U.S.
      • This species infects older RBCs and causes low-level parasitemia and chronic, low-grade infection.
    • P. knowlesi is a monkey malarial parasite that causes occasional human malaria in Southeast Asia and morphologically resembles P. malariae.
      • Infection can rapidly progress to severe illness or death.[8]
      • P. knowlesi can deteriorate rapidly at relatively low parasitemia and warrants initial hospitalization; treat severe disease with IV artesunate regardless of species.[28]

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 8, 2026